BORGHI, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 250
NA - Nord America 222
AS - Asia 39
AF - Africa 4
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 518
Nazione #
US - Stati Uniti d'America 221
IE - Irlanda 66
GB - Regno Unito 56
IT - Italia 28
SE - Svezia 27
RU - Federazione Russa 25
FR - Francia 14
VN - Vietnam 13
SG - Singapore 12
FI - Finlandia 9
DE - Germania 6
UA - Ucraina 6
BE - Belgio 5
ES - Italia 5
CN - Cina 4
IN - India 4
AL - Albania 1
AU - Australia 1
BW - Botswana 1
CA - Canada 1
CI - Costa d'Avorio 1
EU - Europa 1
GH - Ghana 1
HK - Hong Kong 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
KG - Kirghizistan 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
TW - Taiwan 1
UG - Uganda 1
Totale 518
Città #
Dublin 66
Southend 51
Chandler 46
Ashburn 21
Fairfield 16
Dong Ket 13
Singapore 12
Princeton 10
Seattle 10
Ann Arbor 9
Cambridge 9
Helsinki 9
Wilmington 9
Houston 8
Woodbridge 8
New York 6
Milan 5
Málaga 5
Siena 5
Jacksonville 4
Rome 4
London 3
San Mateo 3
Scottville 3
Washington 3
Boardman 2
Brussels 2
Grosseto 2
Leuven 2
Moscow 2
Perugia 2
Redwood City 2
Santa Clara 2
Abidjan 1
Andover 1
Auckland 1
Beijing 1
Bishkek 1
Central 1
Dearborn 1
Gaborone 1
Groningen 1
Gurgaon 1
Henderson 1
Hounslow 1
Lizzanello 1
Melbourne 1
Mestre 1
Munich 1
Nanyang 1
Paris 1
Porto 1
San Diego 1
Sha'av 1
Shanghai 1
Stoney Creek 1
Taipei 1
Temecula 1
Totale 379
Nome #
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 139
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 135
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: an ARCA cohort study 104
Durability and liver safety of INSTI-based regimens in HIV-infected patients with advanced liver fibrosis or cirrhosis: data from the ODOACRE cohort 56
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 55
Efficacy and durability of dolutegravir- or darunavir-based regimens in ART-naïve AIDS- or late-presenter patients 47
Totale 536
Categoria #
all - tutte 2.205
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.205


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 0 0 0 0 0 0 14 3 3 2 3 3
2020/2021123 4 0 0 57 10 10 3 8 11 1 2 17
2021/202268 0 8 3 2 4 5 2 6 2 3 14 19
2022/2023142 7 13 19 9 15 25 5 17 14 5 5 8
2023/2024125 5 1 12 12 8 30 35 0 2 0 7 13
2024/202550 4 11 24 8 3 0 0 0 0 0 0 0
Totale 536